2013 Apr;15(2):119-31. doi: 10.1007/s40272-013-0012-x. Daily dosages of 20 to 360 (median 60 to 70 mg successfully reduce basal acid output to target levels (less than 10 mmol/h or less than 5 mmol/h in patients with severe oesophagitis or partial gastrectomy) during treatment for up to 4 years. 1994 Jul;48(1):91-132. doi: 10.2165/00003495-199448010-00008.Pharmacoeconomics. 1994 Sep;48(3):404-30. doi: 10.2165/00003495-199448030-00007.Drugs. COVID-19 is an emerging, rapidly evolving situation. Clipboard, Search History, and several other advanced features are temporarily unavailable. eCollection 2017.Wang Y, Wang S, Bao Y, Li T, Chang X, Yang G, Meng X.Pharmacogn Mag. Healing rates of greater than 80% are achieved after 8 weeks in patients with severe reflux oesophagitis unresponsive to H2-receptor antagonists. Springer 2017 Apr 14;23(14):2575-2584. doi: 10.3748/wjg.v23.i14.2575. Please enable it to take advantage of the complete set of features! Omeprazole 20 or 40 mg/day has been administered as maintenance therapy for peptic ulcer disease for up to 5.5 years with very few ulcer recurrences. 1999 Apr;94(4):884-7. doi: 10.1111/j.1572-0241.1999.982_e.x.Hassall E, Israel D, Shepherd R, Radke M, Dalväg A, Sköld B, Junghard O, Lundborg P.J Pediatr. doi: 10.1016/s0149-2918(01)80018-7. 1992 Aug;44(2):225-50. doi: 10.2165/00003495-199244020-00007.Gastroenterol Hepatol Bed Bench.

Menu. 1989;166:140-4; discussion 145. doi: 10.3109/00365528909091262.Drugs. Author information: (1)Adis International Limited, Auckland, New Zealand. Patients poorly responsive to treatment with histamine H2-receptor antagonists respond well to omeprazole--most ulcers healed within 4 to 8 weeks of omeprazole 40 mg/day therapy. It is commonly recommended to treat a variety of conditions caused due to excess acid in the stomach, including GERD or acid reflux, peptic ulcer, gastritis etc.It is also effective in healing the damage done to the patient’s esophagus due to excess stomach acid. Omeprazole is well tolerated in short term studies (up to 12 weeks); the reported incidence of serious side effects (about 1%) being similar to that seen in patients treated with an histamine H2-receptor antagonist. This site needs JavaScript to work properly. The longer term tolerability of omeprazole has been investigated in patients treated for up to 5.5 years.

McTavish D(1), Buckley MM, Heel RC. 2020 Winter;13(1):14-22.Molecules. Elsevier Science 2015 May-Jun;29(3):840-6. doi: 10.1111/jvim.12580.

Methods: Studies were identified through searches of MEDLINE and Science Citation Index for the period 1986 to November 2000, and from the reference lists of identified articles.

Prilosec. COVID-19 is an emerging, rapidly evolving situation.

1999 Oct;58(4):725-42. doi: 10.2165/00003495-199958040-00014.Paediatr Drugs. For glandular ulcers a combination of omeprazole and the mucosal protectant Sucralfate is used, with anticipated treatment duration of 28-56 days. Clipboard, Search History, and several other advanced features are temporarily unavailable. 2001 Oct;2(10):1663-70. doi: 10.1517/14656566.2.10.1663.Schenk BE, Kuipers EJ, Klinkenberg-Knol EC, Eskes SA, Meuwissen SG.Am J Gastroenterol. An updated review of its pharmacology and therapeutic use in acid-related disorders. 2017 Sep 4;22(9):1458. doi: 10.3390/molecules22091458.Van Oosten MJ, Silletti S, Guida G, Cirillo V, Di Stasio E, Carillo P, Woodrow P, Maggio A, Raimondi G.Front Plant Sci. 1993 Jun;3(6):482-510. doi: 10.2165/00019053-199303060-00008.Scand J Gastroenterol Suppl. Sorted by User Reviews. 2013 Nov-Dec;4(6):549-67. doi: 10.4161/gmic.27000. Springer (ABSTRACT TRUNCATED AT 400 WORDS) Maintenance therapy with a daily 20 mg dose prevents relapse in about 80% of patients over a 12-month period. Drugs. Omeprazole is considered to be the best pharmacological option for controlling gastric acid secretion in patients with Zollinger-Ellison syndrome. This site needs JavaScript to work properly. Unable to load your delegates due to an error Epub 2015 May 13.J Comput Aided Mol Des. Omeprazole.

This paper reviews the literature on the use and administration of omeprazole for the treatment of GERD, peptic ulcer disease, HP infection, and other acid-related conditions in children. Elsevier Science

Drugs. Omeprazole is a proton pump inhibitor usually indicated to decrease the amount of acid producing in a patient’s stomach.

Epub 2013 Nov 6.Paediatr Drugs.

Omeprazole is the first of a new class of drugs, the acid pump inhibitors, which control gastric acid secretion at the final stage of the acid secretory pathway and thus reduce basal and stimulated acid secretion irrespective of the stimulus.